BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

513 related articles for article (PubMed ID: 19996639)

  • 1. Plasma total homocysteine levels and methylenetetrahydrofolate reductase gene polymorphism in patients with type 2 diabetes mellitus.
    Soares AL; Fernandes AP; Cardoso JE; Sousa MO; Lasmar MC; Novelli BA; Lages GF; Dusse LM; Vieira LM; Lwaleed BA; Carvalho MG
    Pathophysiol Haemost Thromb; 2008; 36(5):275-81. PubMed ID: 19996639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thermolabile methylenetetrahydrofolate reductase enzyme genotype is frequent in type 2 diabetic patients with normal fasting homocysteine levels.
    Tutuncu NB; Erbas T; Alikasifoglu M; Tuncbilek E
    J Intern Med; 2005 May; 257(5):446-53. PubMed ID: 15836661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Study on homocysteine levels and methylenetetrahydrofolate reductase gene variant (C677T) in a population of Buenos Aires City.
    Fridman O; Porcile R; Vanasco V; Junco MN; Gariglio L; Potenzoni MA; Bañes I; Morales A
    Clin Exp Hypertens; 2008 Oct; 30(7):574-84. PubMed ID: 18855261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced serum homocysteine levels in type 2 diabetes.
    Mazza A; Bossone E; Mazza F; Distante A
    Nutr Metab Cardiovasc Dis; 2005 Apr; 15(2):118-24. PubMed ID: 15871860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MTHFR C677T and A1298C gene polymorphisms and hyperhomocysteinemia as risk factors of diabetic nephropathy in type 2 diabetes patients.
    Mtiraoui N; Ezzidi I; Chaieb M; Marmouche H; Aouni Z; Chaieb A; Mahjoub T; Vaxillaire M; Almawi WY
    Diabetes Res Clin Pract; 2007 Jan; 75(1):99-106. PubMed ID: 16828193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The relationship of methylenetetrahydrofolate reductase gene polymorphism and plasma homocysteine levels in type 2 diabetes mellitus patients with diabetic retinopathy].
    Sun J; Xu Y; Zhu Y; Lu H; Deng H; Fan Y; Sun S; Zhang Y
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2003 Apr; 20(2):131-4. PubMed ID: 12673582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mild hyperhomocysteinemia, C677T polymorphism on methylenetetrahydrofolate reductase gene and the risk of macroangiopathy in type 2 diabetes: a prospective study.
    Russo GT; Di Benedetto A; Magazzù D; Giandalia A; Giorda CB; Ientile R; Previti M; Di Cesare E; Cucinotta D
    Acta Diabetol; 2011 Jun; 48(2):95-101. PubMed ID: 19937354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 5,10-methylenetetrahydrofolate reductase common mutations, folate status and plasma homocysteine in healthy French adults of the Supplementation en Vitamines et Mineraux Antioxydants (SU.VI.MAX) cohort.
    Chango A; Potier De Courcy G; Boisson F; Guilland JC; Barbé F; Perrin MO; Christidès JP; Rabhi K; Pfister M; Galan P; Hercberg S; Nicolas JP
    Br J Nutr; 2000 Dec; 84(6):891-6. PubMed ID: 11177206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma total homocysteine levels in children with type 1 diabetes: relationship with vitamin status, methylene tetrahydrofolate reductase genotype, disease parameters and coronary risk factors.
    Dinleyici EC; Kirel B; Alatas O; Muslumanoglu H; Kilic Z; Dogruel N
    J Trop Pediatr; 2006 Aug; 52(4):260-6. PubMed ID: 16401615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlates of total homocysteine plasma concentration in type 2 diabetes.
    Russo GT; Di Benedetto A; Giorda C; Alessi E; Crisafulli G; Ientile R; Di Cesare E; Jacques PF; Raimondo G; Cucinotta D
    Eur J Clin Invest; 2004 Mar; 34(3):197-204. PubMed ID: 15025678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperhomocysteinaemia, methylenetetrahydrofolate reductase polymorphism and risk of coronary artery disease.
    Kerkeni M; Addad F; Chauffert M; Myara A; Gerhardt M; Chevenne D; Trivin F; Farhat MB; Miled A; Maaroufi K
    Ann Clin Biochem; 2006 May; 43(Pt 3):200-6. PubMed ID: 16704755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methylenetetrahydrofolate reductase (MTHFR-677 and MTHFR-1298) genotypes and haplotypes and plasma homocysteine levels in patients with occlusive artery disease and deep venous thrombosis.
    Spiroski I; Kedev S; Antov S; Arsov T; Krstevska M; Dzhekova-Stojkova S; Bosilkova G; Kostovska S; Trajkov D; Petlichkovski A; Strezova A; Efinska-Mladenovska O; Spiroski M
    Acta Biochim Pol; 2008; 55(3):587-94. PubMed ID: 18800176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Further evidence that hyperhomocysteinemia and methylenetetrahydrofolate reductase C677T and A1289C polymorphisms are not risk factors for schizophrenia.
    Vilella E; Virgos C; Murphy M; Martorell L; Valero J; Simó JM; Joven J; Fernández-Ballart J; Labad A
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 Sep; 29(7):1169-74. PubMed ID: 16076517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relation between erythrocyte volume and folate levels is influenced by a common mutation in the methylenetetrahydrofolate reductase (MTHFR) gene (C677T).
    Lalouschek W; Aull S; Serles W; Wolfsberger M; Deecke L; Pabinger-Fasching I; Mannhalter C
    J Investig Med; 2000 Jan; 48(1):14-20. PubMed ID: 10695265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methylenetetrahydrofolate reductase gene, homocysteine and coronary artery disease: the A1298C polymorphism does matter. Inferences from a case study (Madeira, Portugal).
    Freitas AI; Mendonça I; Guerra G; Brión M; Reis RP; Carracedo A; Brehm A
    Thromb Res; 2008; 122(5):648-56. PubMed ID: 18384842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of pre-eclampsia with hyperhomocysteinaemia and methylenetetrahydrofolate reductase gene C677T polymorphism in a Turkish population.
    Yilmaz H; Unlüçerçi Y; Gürdöl F; Isbilen E; Isbir T
    Aust N Z J Obstet Gynaecol; 2004 Oct; 44(5):423-7. PubMed ID: 15387863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contribution of thermolabile methylenetetrahydrofolate reductase variant to total plasma homocysteine levels in healthy men and women. Inter99 (2).
    Husemoen LL; Thomsen TF; Fenger M; Jørgensen HL; Jørgensen T
    Genet Epidemiol; 2003 May; 24(4):322-30. PubMed ID: 12687650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methylenetetrahydrofolate reductase gene polymorphisms in essential hypertension relation: with the development of hypertensive end-stage renal disease.
    Tylicki L; Födinger M; Puttinger H; Rutkowski P; Strozecki P; Tyszko S; Rutkowski B; Hörl WH
    Am J Hypertens; 2005 Nov; 18(11):1442-8. PubMed ID: 16280279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between decreased vitamin levels and MTHFR, MTR and MTRR gene polymorphisms as determinants for elevated total homocysteine concentrations in pregnant women.
    Barbosa PR; Stabler SP; Machado AL; Braga RC; Hirata RD; Hirata MH; Sampaio-Neto LF; Allen RH; Guerra-Shinohara EM
    Eur J Clin Nutr; 2008 Aug; 62(8):1010-21. PubMed ID: 17522601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The MTHFR CT polymorphism confers a high risk for stroke in both homozygous and heterozygous T allele carriers with Type 2 diabetes.
    Hermans MP; Gala JL; Buysschaert M
    Diabet Med; 2006 May; 23(5):529-36. PubMed ID: 16681562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.